Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: A new approach for the diagnosis and prognosis of liver cirrhosis?

Metallomics

Volumn 7, Issue 3, 2015, Pages 491-498

  Costas Rodríguez, Marta ^a   Anoshkina, Yulia ^a   Lauwens, Sara ^a   Van Vlierberghe, Hans ^b   Delanghe, Joris ^b   Vanhaecke, Frank ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BODY FLUIDS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; ISOTOPES; MASS SPECTROMETRY; SODIUM; SPECTROMETRY;

ASPARTATE AMINOTRANSFERASE; DIAGNOSIS AND PROGNOSIS; ICP-MASS SPECTROMETRY; INTERNATIONAL NORMALIZED RATIOS; ISOTOPIC COMPOSITION; MEASUREMENT PROTOCOL; MULTI-COLLECTOR INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; POTENTIAL PARAMETERS;

DIAGNOSIS;

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CERULOPLASMIN; COPPER; PROTHROMBIN; SODIUM; ISOTOPE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; COPPER BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; FLUID RETENTION; HUMAN; HUMAN EXPERIMENT; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MODEL FOR END STAGE LIVER DISEASE SCORE; MONITORING; MORTALITY; MULTICOLLECTOR INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; VERY ELDERLY; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; ISOTOPE LABELING; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REPRODUCIBILITY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; COPPER; FEMALE; HUMANS; ISOTOPE LABELING; ISOTOPES; LIVER CIRRHOSIS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ATOMIC;

EID: 84924980954     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c4mt00319e     Document Type: Article

References (32)

1. W. C. Zhou Q. B. Zhang L. Qiao Pathogenesis of liver cirrhosis World J. Gastroenterol. 2014 21 7312 7324
2. M. D. Runyon AASLD Practice Guidelines Committee, Management of adult patients with ascites due to cirrhosis: an update Hepatology 2009 49 2087 2107
3. M. Valko H. Morris M. T. Cronin Metals, toxicity and oxidative stress Curr. Med. Chem. 2005 12 1161 1208
4. M. E. Letelier A. M. Lepe M. Faúndez J. Salazar R. Marín P. Aracena H. Speisky Possible mechanisms underlying copper-induced damage in biological membranes leading to cellular toxicity Chem.-Biol. Interact. 2005 15 71 82
5. L. A. Videla V. Fernández G. Tapia P. Varela Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells BioMetals 2003 16 103 111
6. G. Poli Pathogenesis of liver fibrosis: role of oxidative stress Mol. Aspects Med. 2000 21 49 98
7. S. A. Arain T. G. Kazi H. I. Afridi F. N. Talpur M. A. Mughal F. Shah S. S. Arain A. H. Panhwar Estimation of copper and iron burden in biological samples of various stages of hepatitis C and liver cirrhosis patients Biol. Trace Elem. Res. 2014 160 197 205
8. S. Lutsenko N. L. Barnes M. Y. Bartee O. Y. Dmitriev Function and regulation of human copper-transporting ATPases Physiol. Rev. 2007 87 1011 1046
9. J. T. Prohanska A. A. Gybina Intracellular copper transport in mammals J. Nutr. 2004 134 1003 1006
10. M. P. Salaspuro P. Pikkarainen P. Sipponen E. Vuori T. A. Miettinen Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment Gut 1981 22 901 906
11. K. Sogawa T. Yamada Y. Suzuki T. Masaki S. Watanabe Y. Uchida K. Arima M. Nishioka K. Matsumoto Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis Res. Commun. Chem. Pathol. Pharmacol. 1994 84 367 370
12. T. P. Mulder A. R. Janssens H. W. Verspaget C. B. Lamers Plasma metallothionein concentration in patients with liver disorders: special emphasis on the relation with primary biliary cirrhosis Hepatology 1991 14 1008 1012
13. G. Gerli G. F. Locatelli R. Mongiat L. Zenoni A. Agostoni G. Moschini D. Zafiropoulos S. Bruno S. Rossi A. Vignati Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver disease Am. J. Clin. Pathol. 1992 97 614 618
14. M. Aramendía L. Rello M. Resano F. Vanhaecke Isotopic analysis of Cu in serum samples for diagnosis of Wilson's disease: a pilot study J. Anal. At. Spectrom. 2013 28 675 681
15. F. Larner B. Sampson M. Rehkämper D. J. Weiss J. R. Dainty S. O'Riordan T. Panetta P. G. Bain High precision isotope measurements reveal poor control of copper metabolism in parkinsonism Metallomics 2013 5 125 132
16. C. N. Maréchal P. Télouk F. Albaréde Precise analysis of copper and zinc isotopic compositions by plasma-source mass spectrometry Chem. Geol. 1999 156 251 273
17. L. Van Heghe E. Engström I. Rodushkin C. Cloquet F. Vanhaecke Isotopic analysis of the metabolically relevant transition metals Cu, Fe and Zn in human blood from vegetarians and omnivores using multi-collector ICP-mass spectrometry J. Anal. At. Spectrom. 2012 27 1327 1334
18. D. C. Baxter I. Rodushkin E. Engström D. Malinovsky Revised exponential model for mass bias correction using an internal standard for isotope abundance ratio measurements by multi-collector inductively coupled plasma mass spectrometry J. Anal. At. Spectrom. 2006 21 427 430
19. M. Costas-Rodríguez L. Lobo F. Vanhaecke A novel approach to measure isotope ratios via multi-collector-inductively coupled plasma-mass spectrometry based on sample mixing with a non-enriched standard Anal. Bioanal. Chem. 2014 406 4393 4399
20. F. Albarède P. Telouk A. Lamboux K. Jaouen V. Balter Isotopic evidence of unaccounted for Fe and Cu erythropoietic pathways Metallomics 2011 3 926 933
21. P. Ginès A. Cárdenas The Management of ascites and hyponatremia in cirrhosis Semin. Liver Dis. 2008 28 43 58
22. C. Le Lan M. Ropert F. Lainé M. Medevielle C. Jard M. Pouchard A. Le Treut R. Moirand O. Loréal P. Brissot Serum Ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic cirrhosis: clinical and pathophysiological implications Alcohol.: Clin. Exp. Res. 2004 5 775 779
23. E. U. Sotil D. M. Jensen Serum enzymes associated with cholestasis Clin. Liver Dis. 2004 8 41 54
24. J. Fevery Bilirubin in clinical practice: a review Liver Int. 2008 592 605
25. H. Tapiero D. M. Townsend K. D. Tew Trace elements in human physiology and pathology. Copper Biomed. Pharmacother. 2003 57 386 398
26. V. I. Reshetnyak Physiological and molecular biochemical mechanisms of bile formation World J. Gastroenterol. 2013 14 7341 7360
27. H. J. Kim H. W. Lee Important predictor of mortality in patients with end-stage liver disease Clin. Mol. Hepatol. 2013 19 105 115
28. F. Durand D. Valla Assessment of prognosis of cirrhosis, Disclosures Semin. Liver Dis. 2008 28 110 122
29. R. Kim S. W. Biggins W. K. Kremers R. H. Wiesner P. S. Kamath J. T. Benson et al., Hyponatremia and mortality among patients on the liver transplant waiting list N. Engl. J. Med. 2008 359 1018 1026
30. D. M. Heuman S. G. Abou-Assi A. Habib L. M. Williams R. T. Stravitz A. J. Sanyal et al., Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death Hepatology 2004 40 802 810
31. M. C. Londoño A. Cárdenas M. Guevara L. Quintó D. de las Heras M. Navasa et al., MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation Gut 2007 56 1283 1290
32. S. W. Biggins W. R. Kim N. A. Terrault S. Saab V. Balan T. Schiano et al., Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology 2006 130 1652 1660